Navigation Links
Rise in Vulvar Precancers Leads to New Guidelines
Date:10/20/2011

THURSDAY, Oct. 20 (HealthDay News) -- The number of American women with precancerous cells of the vulva increased more than fourfold between 1973 and 2000, and the increase has led to the release Thursday of new treatment guidelines by two major medical groups.

Cancer of the vulva -- the outside of the genital area -- is usually caused by infection with human papillomavirus (HPV), which also causes cervical cancer. The precancerous condition -- known as vulvar intraepithelial neoplasia (VIN) -- should be treated with surgery, laser removal or medical therapy, according to the new guidelines from the American College of Obstetricians and Gynecologists and the American Society for Colposcopy and Cervical Pathology.

VIN is divided into two main types. Usual-type VIN is often associated with cancer-causing strains of HPV and risk factors such as smoking and a weakened immune system. Differentiated VIN is often linked to dermatologic conditions of the vulva.

In most cases of VIN, which is increasingly evident among women in their 40s, there are visible raised lesions that may be white, gray, red, brown or black.

"Most women with VIN will not notice any symptoms, but some may have bleeding, discharge, or itching," Dr. Gerald F. Joseph, Jr., ACOG's vice president for practice activities, said in a college news release.

"It would be sensible for women to periodically examine their vulvar area for any unusual spots or lesions, and if they find something, make an appointment with their ob-gyn," he advised.

While VIN appears to be increasing in the United States, the risk of vulvar cancer is small when compared with cervical, ovarian and uterine cancers, Dr. L. Stewart Massad, a member of ACOG's Committee on Gynecologic Practice, said in the news release.

Much like precancerous cervical lesions, VIN is generally slow-growing, he said. "The quadrivalent HPV vaccine that helps prevent cervical cancer and genital warts has also been shown to decrease the risk of VIN," Massad noted.

Visual examination is the only way to diagnose VIN, and most lesions will need to be biopsied. If cancer is suspected, surgery is the preferred treatment. Laser removal is an acceptable treatment for VIN lesions that appear precancerous. Low-grade lesions can be monitored or treated with a topical cream (5 percent imiquimod) for 12 to 20 weeks, according to the guidelines.

The recurrence rate of VIN is high regardless of the treatment method, and women who've had VIN remain at risk for recurrent VIN and vulvar cancer for the remainder of their lives.

-- Robert Preidt

SOURCE: American College of Obstetricians and Gynecologists, news release, Oct. 20, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan
2. Learning Lab of Brentwood Leads Free ADHD Seminar
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
5. Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme
6. New DNA technique leads to a breakthrough in child cancer research
7. AGA leads the way in GI innovation
8. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
9. KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs
10. China's Forbidden City Leads Landmark Climate Action for Earth Hour
11. McMaster researcher leads development of promising drug for inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rise in Vulvar Precancers Leads to New Guidelines  
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: